Taipei’s Bo­ra wants in on the CD­MO game as re­port shows plen­ty of room for in­dus­try growth

Taipei’s Bora Pharmaceuticals has linked up with Taishin Healthcare to invest about $108 million into CDMOs and CROs in response to a booming business environment for both industries. The two …
( read original story …)